Short Antimicrobial Peptide SA-XV Kills Bacteria by Targeting Their Energy Factories | Research

The takeaway

SA-XV, a 15-amino acid fragment of host defense peptide S100A12, kills bacteria by targeting their mitochondria-like energy systems, revealing a novel antimicrobial mechanism.

New killing mechanism
SA-XV targets bacterial energy metabolism from inside the cell — different from conventional membrane-disrupting antimicrobial peptides

What the researchers found

SA-XV, a 15-amino acid S100A12 fragment, killed bacteria through a novel mechanism targeting mitochondria-like energy systems rather than the conventional membrane disruption approach.

Why it matters

A new antimicrobial mechanism means bacteria that resist membrane-targeting peptides may still be killed by SA-XV. Diversifying killing mechanisms is essential for combating antimicrobial resistance.

The numbers in context

Over 2 million people infected with fungi worldwide annually. SA-XV is 15 amino acids long. Targets both Fusarium and Candida species.

How the study worked

Characterized SA-XV antimicrobial activity. Investigated mechanism of action using metabolic and imaging studies. Identified mitochondria-like targeting as the primary killing mechanism.

Who was studied

In vitro: Fusarium spp. and Candida spp. fungal pathogens

What this study cannot tell us

In vitro study. The selectivity for bacterial vs human mitochondria needs evaluation. In vivo efficacy and toxicity unknown. Short peptide stability in biological fluids needs testing.

How to read the evidence

Preliminary evidence: in vitro characterization of a novel antimicrobial mechanism. Safety and in vivo efficacy need evaluation.

When this study was published

Published in 2025. Reveals a novel intracellular antimicrobial peptide mechanism.

The bigger picture

Most antimicrobial peptide development focuses on membrane disruption. SA-XV demonstrates that intracellular targeting of bacterial energy metabolism is an alternative strategy. This expands the antimicrobial peptide toolkit and could yield drugs effective against membrane-resistant bacteria.

Questions still open

Does SA-XV selectively target bacterial energy systems without harming human mitochondria?
Is this mitochondria-targeting mechanism effective against drug-resistant bacteria?
Could SA-XV be combined with membrane-targeting peptides for synergistic killing?

Common questions

How is SA-XV different from other antimicrobial peptides?

Most antimicrobial peptides kill by poking holes in bacterial membranes. SA-XV goes inside the bacterium and disrupts its energy production — like cutting off a city's power supply rather than breaking down its walls. This new mechanism could work against bacteria that resist membrane-targeting peptides.

Is SA-XV from the human body?

Yes — it's a 15-amino acid fragment of S100A12, a protein your immune system naturally produces. Researchers identified this fragment as having potent antimicrobial activity through a novel mechanism, making it a promising template for new antibiotics.

Read the original research

SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections.

The Journal of biological chemistry, 301(10), 110743

View on PubMed ↗Publisher’s paper ↗

Citation

Agarwal, Riddhi; Biswas, Karishma; Agrawal, Akshita; Shankar, Nisha Nandhini; Kundu, Srijita; Roy, Dipanwita; Son, DeokHyun; Harikishore, Amaravadhi; Yennamalli, Ragothaman M; Lee, DongKuk; Bhunia, Anirban; Roy, Sanhita. (2025). SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections.. The Journal of biological chemistry, 301(10), 110743. https://doi.org/10.1016/j.jbc.2025.110743